Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 36,016 shares at $66.20 ($2.4M) on 2024-04-16, disclosed to the SEC on 2024-04-17.
Scheduled sale ($2.4M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.33 | 7,414 | $492K | 20.7% |
| 2 | $66.33 | 7,414 | $492K | 20.7% |
| 3 | $66.20 | 5,834 | $386K | 16.2% |
| 4 | $66.20 | 5,834 | $386K | 16.2% |
| 5 | $65.40 | 9,520 | $623K | 26.2% |
| Total | $66.04 avg | 36,016 |
| $2.4M |
| 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |